Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Hema.to Logo
Hema.to Growth Score
66
CB Rank
43143
Heat Score
17
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
Founded
obfuscation
PrivateSeed München, Bayern, Germany11-50 www.hema.to/
Artificial Intelligence (AI)
Health Care
Health Diagnostics
Overview

Hema.to
Total Funding
obfuscation
Growth Score
66
Heat Score
17

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score66
-4 pts
in past quarter
Heat Score 17
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Hema.to

CB Rank
43143
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
Founded
obfuscation
PrivateSeed München, Bayern, Germany11-50 www.hema.to/
Artificial Intelligence (AI)
Health Care
Health Diagnostics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name hema.to GmbH
Operating Status Active
Company Type For Profit
About the Company
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
Contact Email info@hema.to
Predictions & Insights

Growth Insight

See this Growth Insight
Hema.to is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

hema.to BASE
An AI-powered platform for automated flow cytometry data analysis, providing single cell classification and population detection.
hema.to B-NHL
An AI diagnostic support tool for blood cancer, providing diagnostic recommendations for B-cell non-Hodgkin lymphoma based on flow cytometry data.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed
obfuscation
Seed Round - Hema.to Logo
Seed Round - Hema.to
9
obfuscation
LUMO labsSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Board Members and Advisors 1 Contacts 5

Board Members and Advisors

News

News and Press

News•Feb 27, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 26, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

18,004
2,771.45%
 in past month

IT Spend

$734.9KThis year, Hema.to is projected to spend $734.9K on IT, according to Aberdeen.

Active Website Tech Count

42Hema.to is actively using 42 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  HSTS.

Total IP

3Hema.to has registered 3 trademarks with the most popular class being 'Scientific and electric apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Hema.to's headquarters? Hema.to is located in München, Bayern, Germany.Who invested in Hema.to? Hema.to has 9 investors including Heal Capital and  Elaia.When was the last funding round for Hema.to? Hema.to closed its last funding round on
obfuscation
from a Seed round.Who are Hema.to's competitors? Alternatives and possible competitors to Hema.to may include Sony, Beckman Instruments, and  Omiq.How much funding has Hema.to raised to date? Hema.to has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|